Impact of aging on cancer immunity and immunotherapy.
作者信息
Pawelec Graham, Lustgarten Joseph, Ruby Carl, Gravekamp Claudia
出版信息
Cancer Immunol Immunother. 2009 Dec;58(12):1907-8. doi: 10.1007/s00262-009-0743-2.
Abstract
摘要
相似文献
1
Impact of aging on cancer immunity and immunotherapy.衰老对癌症免疫及免疫治疗的影响。
Cancer Immunol Immunother. 2009 Dec;58(12):1907-8. doi: 10.1007/s00262-009-0743-2.
2
Cancer immunotherapy: focusing on the young, neglecting the old.癌症免疫疗法：关注年轻人，忽视老年人。
Future Oncol. 2010 Jun;6(6):873-6. doi: 10.2217/fon.10.64.
3
Considerations for successful cancer immunotherapy in aged hosts.考虑在老年宿主中成功进行癌症免疫治疗。
Exp Gerontol. 2018 Jul 1;107:27-36. doi: 10.1016/j.exger.2017.10.002. Epub 2017 Oct 4.
4
[Controversial problems in cancer immunology].[癌症免疫学中的争议问题]
Vopr Onkol. 1988;34(4):472-6.
5
Immunosenescence and cancer.免疫衰老与癌症
Biogerontology. 2017 Aug;18(4):717-721. doi: 10.1007/s10522-017-9682-z. Epub 2017 Feb 20.
6
Optimization of immunotherapy in elderly cancer patients.老年癌症患者免疫治疗的优化
Crit Rev Oncog. 2013;18(6):573-83. doi: 10.1615/critrevoncog.2013010591.
7
Considerations for successful cancer immunotherapy in aged hosts.老年宿主成功进行癌症免疫治疗的考量因素。
Clin Exp Immunol. 2017 Jan;187(1):53-63. doi: 10.1111/cei.12875. Epub 2016 Nov 7.
8
Cancer immunotherapy for the elderly.老年癌症免疫疗法。
Nat Rev Immunol. 2013 Nov;13(11):774. doi: 10.1038/nri3557. Epub 2013 Oct 11.
9
The complicated effects of obesity on cancer and immunotherapy.肥胖对癌症和免疫疗法的复杂影响。
Immunotherapy. 2019 Jan;11(1):11-14. doi: 10.2217/imt-2018-0133.
10
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity.衰老、肥胖和微生物组对肿瘤免疫治疗疗效和毒性的影响。
Int J Mol Sci. 2019 Jul 23;20(14):3586. doi: 10.3390/ijms20143586.
引用本文的文献
1
Treatment rationale and design of the PROLONG study: safety and efficacy of pembrolizumab as first-line therapy for elderly patients with non-small cell lung cancer.PROLONG研究的治疗原理与设计：帕博利珠单抗作为老年非小细胞肺癌患者一线治疗的安全性与疗效
J Thorac Dis. 2020 Mar;12(3):1079-1084. doi: 10.21037/jtd.2019.12.46.
2
mTOR and Aging: An Old Fashioned Dress.mTOR 与衰老：复古的装扮。
Int J Mol Sci. 2019 Jun 6;20(11):2774. doi: 10.3390/ijms20112774.
3
Progressive ossification of the bone marrow vasculature with advancing age corresponds with reduced red blood cell count and percentage of circulating lymphocytes in male Fischer-344 rats.随着年龄的增长，骨髓血管逐渐骨化，雄性 Fischer-344 大鼠的红细胞计数和循环淋巴细胞百分比减少。
Microcirculation. 2019 Nov;26(8):e12550. doi: 10.1111/micc.12550. Epub 2019 Jun 17.
4
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.75 岁及以上的老年黑色素瘤患者对抗 PD-1 治疗仍有反应：一项回顾性单机构队列研究的结果。
Cancer Immunol Immunother. 2018 Oct;67(10):1571-1578. doi: 10.1007/s00262-018-2219-8. Epub 2018 Jul 28.
5
Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix.克服年龄障碍以提高癌症免疫治疗疗效：细胞外基质的影响力
Front Cell Dev Biol. 2018 Mar 1;6:19. doi: 10.3389/fcell.2018.00019. eCollection 2018.
6
Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.循环中产生促炎和/或抗炎细胞因子的Her-2反应性T细胞对老年乳腺癌患者的预后影响
J Immunother Cancer. 2015 Oct 20;3:45. doi: 10.1186/s40425-015-0090-0. eCollection 2015.
7
Oral Intake of Carboxymethyl-Glucan (CM-G) from Yeast (Saccharomyces uvarum) Reduces Malondialdehyde Levels in Healthy Men.口服来自酵母（葡萄汁酵母）的羧甲基葡聚糖（CM-G）可降低健康男性体内的丙二醛水平。
Molecules. 2015 Aug 14;20(8):14950-8. doi: 10.3390/molecules200814950.
8
Aging, nutrient signaling, hematopoietic senescence, and cancer.衰老、营养信号传导、造血衰老与癌症。
Crit Rev Oncog. 2013;18(6):559-71. doi: 10.1615/critrevoncog.2013010596.
9
Aging, cancer, and cancer vaccines.衰老、癌症和癌症疫苗。
Immun Ageing. 2012 Apr 17;9(1):4. doi: 10.1186/1742-4933-9-4.
10
Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.前列腺癌去势抵抗治疗中 sipuleucel-T 的免疫治疗的跨学科批判。
J Natl Cancer Inst. 2012 Feb 22;104(4):273-9. doi: 10.1093/jnci/djr514. Epub 2012 Jan 9.
Zotero 插件